Abstract
Low socioeconomic status (SES) is associated with early onset of chronic diseases and reduced life expectancy. The involvement of neighborhood-level factors in defining cancer risk and outcomes for marginalized communities has been an active area of research for decades. Yet, the biological processes that underlie the impact of SES on chronic health conditions, such as cancer, remain poorly understood. To date, limited studies have shown that chronic life stress is more prevalent in low SES communities and can affect important molecular processes implicated in tumor biology such as DNA methylation, inflammation, and immune response. Further efforts to elucidate how neighborhood-level factors function physiologically to worsen cancer outcomes for disadvantaged communities are underway. This review provides an overview of the current literature on how socioenvironmental factors within neighborhoods contribute to more aggressive tumor biology, specifically in Black U.S. women and men, including the impact of environmental pollutants, neighborhood deprivation, social isolation, structural racism, and discrimination. We also summarize commonly used methods to measure deprivation, discrimination, and structural racism at the neighborhood-level in cancer health disparities research. Finally, we offer recommendations to adopt a multi-faceted intersectional approach to reduce cancer health disparities and develop effective interventions to promote health equity.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Despite a decreasing cancer mortality for Black individuals living in the U.S. over the past 20 years, including African Americans and individuals of African descent living in the U.S., Black women and men continue to experience significantly higher overall cancer mortality rates than other U.S. population groups [1]. Targeted therapies and interventions to help ameliorate health disparities and promote health equity in the Black community are increasing. Still, are our current efforts sufficiently comprehensive to achieve health justice for this community? Black Americans have endured unimaginable hardships over centuries, from the atrocities of slavery to racist Jim Crow laws and discriminatory housing and financial practices, making upward mobility all but impossible for Black Americans. All these historical factors led to deprived and segregated living conditions of many Black communities, in which neighborhoods lack clean air, healthy food options, or access to adequate healthcare [2,3,4,5].
Research has shown that where we live has a profound impact on our health [6,7,8]. One long-term follow-up study found that neighborhood-level factors, including socioeconomic disadvantage and lack of healthcare access, translated to a 50% increase in all-cause mortality for those living in the most deprived neighborhoods [9]. This mortality rate increased to 90% when considering the mortality specific to prostate cancer. This trend has also been observed in other cancer types, including breast cancer, where Black women in low socioeconomic neighborhoods have greater odds of a late-stage diagnosis, higher grade tumors, more aggressive breast cancer subtypes, and increased mortality [10,11,12,13]. In the context of cancer, the influence of neighborhood factors on mortality literally translates to life or death.
How the neighborhood environment impacts cancer risk and mortality is complex and includes a myriad of social, environmental, economic, and structural factors that combine to produce more aggressive tumors and poorer cancer outcomes for these historically marginalized populations. For example, neighborhood-level redlining, defined as the historic and systematic denial of mortgage lending in certain neighborhoods with a high proportion of Black, foreign-born, or low-income residents [14], correlates with late-stage cancer diagnosis and an elevated risk of experiencing lethal breast, lung, cervical, and colorectal cancer [14,15,16,17]. Additionally, structural racism, or the way in which society perpetuates racist beliefs and practices through mutually reinforcing systems [18], has also been implicated as a causal factor in cancer disparities, accounting for a proportion of the differences in cancer survival outcomes between racial groups for certain cancer types [19, 20]. These studies and others reveal how structural racism, coupled with economic disinvestment in neighborhoods, can have a direct impact on the health of its residents.
A growing body of evidence points to ancestry-related, stress-dependent, and environmentally induced mechanisms that alter tumor biology and cancer survival outcomes, thereby contributing to cancer disparities. Many of the stress-dependent and environmental risks have their origin in both the physical and social environments. This narrative review primarily discusses literature published in the last 5 years. Our aims were to (1) summarize these findings as they relate to aggressive tumor biology; (2) review tools for measuring neighborhood-level factors as they relate to health disparities; and (3) discuss recommendations to mitigate the impact of these neighborhood-level factors on cancer biology and outcomes.
Methods to measure deprivation, discrimination, and structural racism at the neighborhood-level
With an increasing interest in health disparities research over the past decade, it is imperative that researchers avoid health equity tourism, or the pivot of inexperienced researchers into health equity work without the necessary expertise or sound methodologies to produce high-quality health disparities studies [21, 22]. We, as health disparities researchers, must not only ensure our study populations are well-represented in all relevant demographics to ensure statistically meaningful results, but also keep a health equity lens when designing these studies through careful consideration of the methods used to measure the factors that influence the health of historically marginalized populations. We will outline and discuss commonly used tools for measuring neighborhood-level factors, as these have been shown to impact cancer patients on many levels, including their cancer risk, care, and outcomes [23,24,25,26].
Neighborhood deprivation
The effects of neighborhood-level factors on health are an important consideration in health disparities research. Biological differences in cancer risk factors between population groups often originate from the neighborhood environment [27]. Researchers have developed several publicly shared deprivation indices intended to measure social and economic factors that determine a neighborhood’s deprivation level. Many of these are based on tracts from the U.S. Census determined via participant residential zip code or address, while others use county level indicators as the unit of analysis. One of the most popular indices used to measure area socioeconomic deprivation is the Neighborhood Deprivation Index (NDI), introduced by Messer et al. [28]. The NDI uses Census-tracts as the unit of analysis as these are generally small, relatively permanent boundaries for counties, and designed to be homogenous with respect to social and economic factors [29]. Overall, the NDI uses data reduction methods to empirically summarize five key socio-demographic domains previously shown to be associated with health outcomes, including education, income/poverty, employment, housing, and occupation [28]. Similarly, the Area Deprivation Index (ADI) is another commonly used comprehensive index composed of 17 indicators within similar domains as the NDI [30, 31]. As a point of comparison, the NDI has been used longer and has been extensively implemented in the public health literature. In contrast, the ADI is newer, but is a database that includes all U.S. neighborhoods and is regularly maintained and updated. While there are other deprivation indices available [32,33,34,35,36,37], the NDI and ADI are two of the most comprehensive metrics of U.S.-based neighborhood deprivation currently used. For further discussion of area-based socioeconomic indices, several reviews, including a recent scoping review by Trinidad et al., compares these indices in greater detail [38, 39].
Racism and discrimination
The development of sound techniques for measuring both individual- and structural-level racism and discrimination are imperative to achieving health equity. This includes both quantitative and qualitative methods that are reproducible and able to be validated in many different contexts, including health disparities research [40]. On an individual level, racism and discrimination have been measured using various scales, each attempting to capture different facets of an individual’s experience with perceived racism and discrimination. These include the Major and Everyday Discrimination Scales [41], the Experiences of Discrimination measure [42, 43], the Racial Microaggressions Scale [44], and the Race-related Events Scale [45], among others. Several context-dependent adaptions of the Everyday Discrimination Scale are also routinely used, such as the Discrimination in Medical Settings scale [46,47,48], with the aim of capturing patient experience with perceived racial discrimination when receiving health care and services.
In a much broader context, measuring structural racism is a more arduous task, but it is crucial to breaking down the mutually reinforcing systems that perpetuate racist ideals and beliefs within societies, communities, and neighborhoods, which ultimately have an impact on health [40, 49, 50]. Several studies and commentaries have summarized prominent factors to consider when measuring structural racism, including residential segregation and housing discrimination, perceived racism in social institutions, SES, criminal justice, civil rights laws and legal racial discrimination, and workplace environment [51, 52]. While these components of structural racism have historically been modeled separately, the intersectionality of these measures is also an important consideration in determining the collective and interactive effects of structural racism on the health and cancer outcomes in historically marginalized populations [53,54,55]. To this end, a recent paper by Dougherty et al. created a multi-indicator scale to measure structural racism at the county-level in the U.S. using publicly available data [56], providing significant advancement in the development of methodological approaches to measure structural racism.
The impact of environmental factors on tumor biology
How the built environment impacts health and cancer outcomes has been widely studied for decades, especially considering that we spend most of our time either at home or at work. Living conditions, street layout, accessible green spaces, light at night, walkability, and other infrastructures affect food access and dietary choices, physical activity levels, environmental exposures, and behavioral and lifestyle habits [57,58,59,60]; which all directly impact our health, including our cancer risk. Little data exists, however, directly connecting these factors to tumor biology and more work is needed in this area. Here, we will describe how environmental factors, including pollution and neighborhood socioeconomic deprivation, impacts biological outcomes that either directly or indirectly lead to an altered tumor biology and adverse cancer outcomes. We will assess how environmental factors, including environmental pollution and neighborhood socioeconomic deprivation, impact biological processes that either directly or indirectly influence tumor biology and cancer outcomes. For the purpose of this review, we will concentrate on air pollution as an environmental risk factor, as there exists a more established mechanistic link between it and tumor biology compared to other environmental exposures, for which much of the available data is focused on cancer risk.
Environmental racism and air pollution
Residential segregation created and perpetuated by discriminatory housing policies in the U.S. has led to racial and ethnic minoritized groups to be concentrated in neighborhoods that have often been economically and politically disempowered [61]. A central side effect of this community disinvestment is lower commercial and residential property values, making land in these areas easier and cheaper to acquire for industrial interests. Proximity of predominantly Black communities to these industrial sites means greater exposure to the environmental hazards known to adversely impact human health, e.g., waste disposal, toxic dumping, oil and gas extraction, and close presence of power plants, petrochemical facilities, and Superfund sites. 70% of Superfund sites, which are areas declared to be severely contaminated by the U.S. Environmental Protection Agency (EPA), are located within one mile of federally-funded housing, in which a disproportionate number of low-income and Black Americans reside [62]. Further, intentional placement of highways, bus depots, landfills, and incinerators in historically segregated neighborhoods has resulted in significantly higher concentrations of air pollutants [63, 64]. Ultimately, the concentrated presence of these hazardous and undesirable factors lowers property values and thus perpetuates a vicious cycle of poverty and disproportionate environmental harm on Black communities in the U.S., now termed environmental racism. The insidious effects of environmental racism can adversely impact cancer risk, biology, and survival in several ways.
Exposure to outdoor air pollution poses an increasingly urgent public health challenge to all people living in the U.S. and worldwide; however, exposure to air pollutants and their detrimental impact on health is disproportionately high in certain communities. It is well-documented that air pollution is segregated by race and SES [65]. Large-scale reviews funded by the NIEHS have found unequal distribution of air pollution in the U.S., with greater exposure to air pollution in poorer communities [66, 67]. The findings identified air pollution as a contributor to health disparities [68]. Epidemiologic studies have reported an elevated risk of cancer driven by specific air pollutants, such as fine particulate matter that measure less than 2.5 microns (PM2.5) and coarse fraction particles that measure between 2.5 and 10 microns (PM10) [69]. Other commonly studied pollutants in cancer incidence and mortality include carbon monoxide (CO) [70], gaseous ozone (O3) [71], nitrogen dioxide (NO2) [72], pesticides, and a variety of others, all of which have been linked in various ways to increased cancer risk.
Representing a heterogeneous mixture of organic, inorganic, and biologic compounds [69, 73], PM2.5 is a one of the most used metrics for air quality and is actively studied in relation to cancer. The origin of these fine particles outdoors can be traced to automobiles, construction exhausts, and even power plants, all of which are elevated in polluted areas and thus, on average, more concentrated in communities with predominantly Black residents. While larger particulates, such as PM10, are generally caught in the nose and throat and not the lung [69], PM2.5 can be inhaled and deposited deeply into lung tissue, thus making it a major focus of lung cancer research. However, studies have shown PM2.5 may also increase the risk of developing multiple other cancers, including colon [74], prostate [75], and bladder, independent of cigarette smoking [76,77,78]. PM2.5 levels have also been positively associated with breast cancer incidence [79, 80], though epidemiologic evidence for this relationship has been somewhat less consistent and has been weakened by several null studies [81, 82]. Accordingly, PM2.5 has been designated an IARC Group 1 carcinogen. In addition to risk, it is well-established that air pollution levels have been shown to lead to poorer survival in cancer patients [79, 83, 84] A number of recent reviews provide an excellent, in-depth compilation of evidence linking both outdoor and indoor air pollution to inflammation [85], cancer [69, 86], and health [87].
The precise biological mechanisms that mediate the effects of various air pollutants in carcinogenesis and tumor biology are still being investigated and large gaps in knowledge exist. Most of the literature has historically focused on effects of various air pollutants along the respiratory tract. Several studies have found that air pollution, which contains groups of mutagenic and carcinogenic compounds, increases the formation of DNA adducts [88,89,90]. Further, several studies have identified inactivating somatic mutations and epigenetic silencing in TP53 and other tumor suppressor genes that are linked to environmental exposures [91,92,93,94]. A recent study in 2020 by Letellier et al. uncovered associations between PM2.5 and NO2 exposures that occurred 5- to 10-years prior to cancer diagnosis with somatic mutations in the TP53 gene in non-small cell lung cancer patients [95]. Zhenzhen Wang et al. proposed an interesting mechanism based on their recent animal study, whereby fine particulate matter in air pollutants promoted lung cancer progression through thickening of the tissue matrix, which restricted infiltration by immune cells with antitumor activity. They identified a mediator of collagen IV crosslinking called peroxidasin (PXDN) as the enzyme responsible for this overly dense matrix [96].
Overall, air pollution has been linked to increased low grade inflammation [97] and oxidative stress [98], both of which have been found to initiate or exacerbate cancer across multiple cancer types. However, fewer studies have endeavored to examine air pollution beyond the respiratory tract. A 2019 study by Reyes-Caballero et al. demonstrated substantial metabolic dysregulation in glucose and lipid metabolism in the liver after exposure of mice to PM2.5 [99]. While this investigation was conducted in the context of insulin resistance and type II diabetes, its biological implication may extend to cancer where energetic dysregulation plays an important role in tumor biology.
Neighborhood deprivation
While several studies have investigated the link between neighborhood disadvantage and cancer risk and outcomes [100,101,102,103,104,105], there is a paucity of studies directly investigating the biological impact of neighborhood socioeconomic deprivation on the molecular underpinnings of tumors. This growing area of research is important, as knowledge of how the neighborhood influences biological pathways will broadly inform the cancer research community, beyond health disparity research, linking the environment to individual cancer risk, tumor characteristics, disease aggressiveness, and survival. This research will also be instrumental to establish both proof of causality and socioenvironmental influences as bona fide cancer risk factors.
One potential underlying pathway in which neighborhood deprivation influences cancer biology is through accelerated biological aging. Powell-Wiley et al. investigated the relationship between neighborhood deprivation and leukocyte telomere length using samples from the National Health and Nutrition Examination Surveys (NHANES). The length of telomeres, which are the protective caps that prevent the ends of chromosomes from deteriorating, are markers of biological aging and are associated with genomic instability and cancer risk [106]. This study found that individuals living in both medium and high deprivation neighborhoods had significantly shorter telomere length, pointing to accelerated aging as a potential biological mechanism for the negative impacts of socioeconomic disadvantage on health [107]. This hypothesis was tested in a cancer context in a more recent follow-up study, in which Shen et al. investigated the impact of neighborhood disadvantage on several markers of biological aging including allostatic load, telomere length, and DNA methylation in a cohort of recently diagnosed breast cancer patients [11]. They reported that individuals from a neighborhood with high deprivation were 20% more likely to experience an increased allostatic load, in addition to a large decrease in global methylation, when compared to individuals from a deprived neighborhood. They did not, however, find an association between neighborhood deprivation and telomere length in their study cohort [108, 109].
Other studies on the impact of neighborhood deprivation on telomere length observed that with each unit of improvement in neighborhood SES, there was a proportional incremental decrease in telomere length attrition [110, 111]. Yet, a meta-analysis on this topic did not support the existence of a robust relationship between neighborhood disadvantage and premature aging defined by telomere length attrition [112]. Thus, the interrelationship between neighborhood deprivation and biological aging markers and cancer is likely complex. More studies are needed to determine the biological mechanisms mediating the negative effects of neighborhood deprivation on accelerated aging and its impact on cancer.
Chronic inflammation due to a deprived neighborhood environment has also been shown to have an impact on tumor biology. The studies that address this topic directly point to chronic stress as a leading driver of neighborhood deprivation-based inflammation, resulting in a more aggressive tumor biology [27, 63, 113, 114]. In addition to the negative behavioral habits that chronic stress imposes upon an individual that may increase cancer risk (e.g., tobacco use, alcohol consumption, poor diet), prolonged stress stimuli increase the allostatic load, a composite index commonly used to estimate stress-induced biological risk over the life course [115]. This triggers the development of stress-related diseases, such as cancer, through suppression of immunological responses via increased levels of circulating stress hormones, like catecholamines and glucocorticoids [27, 116, 117]. Additionally, individuals living in more deprived neighborhoods have been shown to experience increased levels of proinflammatory biomarkers, such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor receptor-2 [118,119,120]. Recent meta-analyses summarized the impact of SES on inflammatory markers, specifically CRP and IL-6, and found that lower SES associates with higher levels of these markers and systemic inflammation, defining inflammation as a candidate mechanism for the adverse impact of SES on overall health [121, 122]. Additional emphasis needs to be placed on the role of socioenvironmental determinants in influencing these inflammatory biomarker levels and stress response stimuli that can, in turn, exacerbate tumor aggressiveness and negatively influence cancer outcomes.
Effects of the social environment on tumor biology
Much like the physical environment, our social experiences can greatly impact our health including our stress levels, mental health, social relationships, and overall well-being. This is especially important in cancer, as several studies have confirmed that inadequate social support can lead to a marked increase in cancer mortality [123,124,125]. It has been postulated that this association stems from socially isolated individuals having decreased instrumental support regarding their cancer treatment and care. Additionally, socially supported individuals have the benefit of “social control”, the concept that people with strong networks are healthier because negative health behaviors are discouraged [126, 127]. There has been evidence, however, that social experiences can also impact basic biological functioning which, in turn, could impact tumor biology. Here, we discuss how social factors, including social support networks and racial discrimination, impact biological function including cancer biology and outcomes.
Social environment
A person’s social environment bears a great impact on health and wellness, both mental and physical. This extends to individuals living with cancer, where an adverse social environment, including social isolation, has been repeatedly associated with reduced survival across multiple cancer types [123, 124]. Social isolation, defined as a lack of social interaction, can be measured using criteria that is both objective (e.g., social network size, number/frequency of interactions with other individuals) and subjective (e.g., perceived social isolation or loneliness at the individual level) [127]. At the neighborhood level, social cohesion—which is defined as the network of relationships, shared values, and norms [128]—has been identified as a primary contributor to individual health [129]. Social cohesion is usually determined through subjective measures based on perceptions of trust, helpfulness, and other positive metrics among neighbors [130]. Traditional theories explaining the positive effects of both social cohesion and support on health outcomes have rested heavily on positive social influence to deter negative health behaviors using observational and intervention studies [126]. However, now that researchers have recapitulated these effects in animal models [131,132,133], the field has more recently embraced alternate explanations based in the physiological response to a positive social environment. While no causal mechanisms have been firmly established to date, research examining how cancer initiation and progression is influenced by the classical stress response through activation of the sympathetic nervous system and hypothalamic–pituitary–adrenal axis is an active area of study [134,135,136,137].
Social isolation has been documented as a chronic stressor and is associated with elevated stress-induced hormones [138]. Beta-adrenergic signaling has been shown to increase cancer invasion, survival, and angiogenesis, as well as modulate tumor-immune interactions [139]. This includes release of glucocorticoids, which have been associated with experiencing loneliness and the activation of downstream cellular processes [140]. Oxytocin, which is released during social and physical contact [126], has also been implicated as a mediator between stress and cancer, though direct evidence is still lacking. The effects of stress on cellular aging have also been explored in this context, which is particularly relevant to Black individuals, as accelerated aging has been shown to be associated with racial discrimination [141, 142]. A study by Brody et al. found supportive family environments modify the effects between racial discrimination and epigenetic aging [143]. In a recent longitudinal study conducted in 2022 by Hailu et al. within the Multi-Ethnic Study of Atherosclerosis, neighborhood social cohesion modified the effect of discrimination on telomere length attrition in leukocytes [144]. While causal mechanisms remain to be established, some of the biological ramifications of the neighborhood social environment have been elucidated and appear to have a tangible impact on cancer progression and survival.
Racism and discrimination
Methods to measure racism and discrimination accurately and cohesively, including structural racism, are steadily emerging, which will bring forth new studies on how the health of marginalized communities are impacted by these discriminatory practices. Past studies have related racism and discrimination directly to cancer outcomes, with the overall consensus that living in areas with high levels of structural and institutional racism, both past and present, are associated with greater odds of more aggressive cancers and poorer survival outcomes for Black individuals [4, 20, 145]. The effects of racism and discrimination on cancer outcomes can be attributed not only to the impact that racism has on cancer care for Black individuals, but also the body’s physical and mental response to the stress of perceived racism and discrimination. Recent studies have shown racial disparities in not only end-of-life care for individuals with metastatic cancer [146], but also the presence of high levels of distrust and negative attitudes among Black cancer patients toward physician practices, especially when the patient-physician relationship is racially-discordant or there are past patient experiences of medical racism [147,148,149]. Interventions to reduce medical bias, as well as improve patient beliefs/attitudes toward cancer care, will be imperative in improving cancer outcomes for marginalized populations.
From a biological perspective, there is a gap in the literature directly linking quantitative or qualitative measures of racism and discrimination to more aggressive tumor biology, specifically as it relates to Black individuals. Studies that have investigated the biological impact of racial discrimination on health implicated stress, depression, inflammation, immune response, and accelerated cellular aging as mediators in this relationship. A 2015 prospective cohort study on perceived racial discrimination on diurnal cortisol levels showed that the effects of perceived racial discrimination on cortisol levels were more pervasive for Black individuals, especially during adolescence when developmental periods are more sensitive [150]. Stress and depressive symptoms have also been shown to mediate the relationships between discrimination and smoking and discrimination and obesity, with smoking and obesity being on their own major risk factors for cancer [151, 152]. Additionally, the effects of racial discrimination on accelerated aging have mostly been performed in the context of telomere length, and much like the effects of neighborhood deprivation on health, several studies have shown an inverse relationship between increased early life racial discrimination and shorter telomere length, specifically among Black adolescent males [141, 142, 153, 154].
Coming back to inflammation, multiple studies have linked gender- and race-related discrimination to inflammatory markers (such as CRP and IL-6), concluding that racism and discrimination appear to have a direct impact on these markers after adjusting for relevant covariates and upregulate them [155,156,157]. Further studies have linked adverse cardiovascular outcomes to racism and discrimination in Black individuals, concluding that this population experiences an excessive risk of hypertension due to these discriminatory practices [158, 159]. Moreover, Black individuals may also experience an overall decline in health through continued exposure to social and economic disadvantage (also known as the “weathering hypothesis”) [160,161,162,163]. Additional research is needed to better understand the biologic effects of racism and discrimination, especially structural racism, on cancer outcomes so that effective interventions can be created.
A path forward
Integrating exposures from both the social and environmental factors into studies that seek to understand the aggressive tumor biology in Black individuals from the U.S. is essential to reduce the excessive cancer mortality experienced by this population (see Fig. 1). This avenue of research can no longer be performed in silo. We will outline three recommendations for cancer disparities researchers to help eliminate health disparities and move toward health equity.
First, basic scientists must collaborate and communicate with experts in social and environmental epidemiology when addressing questions related to cancer disparities in marginalized populations. As this review has summarized, the worsened outcomes and more aggressive tumor biology in Black individuals with cancer is likely mediated by underlying biological processes stimulated by the effects of socioenvironmental factors (e.g., neighborhood deprivation, environmental hazards, racial discrimination). Therefore, we must encourage cross-training of cancer disparities researchers to be able to approach this complex problem from multiple perspectives, including designing studies that assess both the social and biological contributors of more aggressive disease and worse cancer outcomes among Black Americans.
Second, we must embrace the fact that no one single exposure, social or biological, causes cancer disparities. These factors work in concert to inflict a milieu of biological effects on its host that makes tumors more aggressive and worsens outcomes for individuals from disadvantaged backgrounds. As such, we must now focus on the interaction between these exposures. Much like polygenic risk scores encompass all known relevant genetic factors to determine genetic risk for a specific disease state, polysocial risk scores must now be established, validated, and then integrated as a method to determine an individual’s social risk for disease [164,165,166]. These scores should be updated over time, as the underlying risk profiles can fluctuate [167]. Moreover, continued and expanded research on exposomes, which describe the totality of exposures (both internal and external) impacting an organism’s health over its life course, will be necessary to better understand the interactive and additive effects that social, psychosocial, and environmental components have on biological health outcomes, especially for individuals from marginalized communities [162, 168,169,170].
Third, the impact of these social and environmental factors on tumor biology will eventually lead to the identification of novel therapeutic targets that could hold promise for new treatments. However, it is critical to ensure equitable access to such treatments through promoting and encouraging the participation of systematically excluded populations in research studies and clinical trials, including as scientists and/or as study participants. This involves (1) increasing research funding and support for Black investigators at all levels, (2) carefully designing cancer disparities studies to be inclusive in both language and study population, and (3) actively engaging stakeholders, collaborators, and community advocates from minoritized populations as leaders on these studies.
The field of racial disparities in cancer has come a long way and has advanced in its scientific rigor with the use of more integrative approaches, but the work is far from over. Additional well-executed studies are needed to decipher the relationship between neighborhood-level factors and tumor biology as it relates to cancer outcomes. We must embrace the complexities and myriad of factors that define cancer risk, development, and progression, both socially and biologically, in diverse populations to design appropriate interventions and strategies to mitigate the impact of this disease on the most vulnerable communities in the U.S.
Data availability
All studies cited in this review are publicly available.
References
Lawrence WR, McGee-Avila JK, Vo JB, Luo Q, Chen Y, Inoue-Choi M, de Berrington Gonzalez A, Freedman ND, Shiels MS (2022) Trends in cancer mortality among black individuals in the US from 1999 to 2019. JAMA Oncol 8(8):1184–1189
Williams DR, Collins C (2001) Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep 116(5):404–416
Annesi CA, Poulson MR, Mak KS, Tapan U, Dechert TA, Litle VR, Suzuki K (2022) The impact of residential racial segregation on non-small cell lung cancer treatment and outcomes. Ann Thorac Surg 113(4):1291–1298
Zhou Y, Bemanian A, Beyer KM (2017) Housing discrimination, residential racial segregation, and colorectal cancer survival in southeastern wisconsin. Cancer Epidemiol Biomarkers Prev 26(4):561–568
Ojinnaka CO, Luo W, Ory MG, McMaughan D, Bolin JN (2017) Disparities in surgical treatment of early-stage breast cancer among female residents of Texas: the role of racial residential segregation. Clin Breast Cancer 17(2):e43–e52
Carmona M (2019) Place value: place quality and its impact on health, social, economic and environmental outcomes. J Urban Des 24(1):1–48
Robinette JW, Charles ST, Gruenewald TL (2017) Neighborhood socioeconomic status and health: a longitudinal analysis. J Community Health 42(5):865–871
Diez Roux AV, Mair C (2010) Neighborhoods and health. Ann N Y Acad Sci 1186:125–145
Kc M, Oral E, Rung AL, Trapido EJ, Rozek LS, Fontham ETH, Bensen JT, Farnan L, Steck SE, Song L et al (2022) Neighborhood deprivation and risk of mortality among men with prostate cancer: findings from a long-term follow-up study. Prostate 82(7):783–792
Smith BP, Madak-Erdogan Z (2018) Urban neighborhood and residential factors associated with breast cancer in African American Women: a systematic review. Horm Cancer 9(2):71–81
Shen J, Fuemmeler BF, Sheppard VB, Bear HD, Song R, Chow WH, Zhao H (2022) Neighborhood disadvantage and biological aging biomarkers among breast cancer patients. Sci Rep 12(1):11006
Babatunde OA, Zahnd WE, Eberth JM, Lawson AB, Adams SA, Boakye EA, Jefferson MS, Allen CG, Pearce JL, Li H et al (2021) Association between neighborhood social deprivation and stage at diagnosis among breast cancer patients in South Carolina. Int J Environ Res Public Health 18(22):11824
Qin B, Babel RA, Plascak JJ, Lin Y, Stroup AM, Goldman N, Ambrosone CB, Demissie K, Hong CC, Bandera EV et al (2021) Neighborhood social environmental factors and breast cancer subtypes among Black women. Cancer Epidemiol Biomark Prev 30(2):344–350
Krieger N, Wright E, Chen JT, Waterman PD, Huntley ER, Arcaya M (2020) Cancer stage at diagnosis, historical redlining, and current neighborhood characteristics: breast, cervical, lung, and colorectal cancers, Massachusetts, 2001–2015. Am J Epidemiol 189(10):1065–1075
Collin LJ, Gaglioti AH, Beyer KM, Zhou Y, Moore MA, Nash R, Switchenko JM, Miller-Kleinhenz JM, Ward KC, McCullough LE (2021) Neighborhood-level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area. Cancer Epidemiol Biomark Prev 30(1):53–60
Plascak JJ, Beyer K, Xu X, Stroup AM, Jacob G, Llanos AAM (2022) Association between residence in historically redlined districts indicative of structural racism and racial and ethnic disparities in breast cancer outcomes. JAMA Netw Open 5(7):e2220908
Beyer KMM, Zhou Y, Laud PW, McGinley EL, Yen TWF, Jankowski C, Rademacher N, Namin S, Kwarteng J, Beltran Ponce S et al (2021) Mortgage lending bias and breast cancer survival among older women in the United States. J Clin Oncol 39(25):2749–2757
Bailey ZD, Krieger N, Agenor M, Graves J, Linos N, Bassett MT (2017) Structural racism and health inequities in the USA: evidence and interventions. Lancet 389(10077):1453–1463
Abraham IE, Rauscher GH, Patel AA, Pearse WB, Rajakumar P, Burkart M, Aleem A, Dave A, Bharadwaj S, Paydary K et al (2022) Structural racism is a mediator of disparities in acute myeloid leukemia outcomes. Blood 139(14):2212–2226
Eldridge L, Berrigan D (2022) Structural racism and triple-negative breast cancer among black and white women in the United States. Health Equity 6(1):116–123
Lett E, Adekunle D, McMurray P, Asabor EN, Irie W, Simon MA, Hardeman R, McLemore MR (2022) Health equity tourism: ravaging the justice landscape. J Med Syst 46(3):17
McFarling UL (2022) ‘Health equity tourists’: How white scholars are colonizing research on health disparities. 2021, 2022(August 30, 2022)
Nelson B (2020) How structural racism can kill cancer patients: Black patients with breast cancer and other malignancies face historical inequities that are ingrained but not inevitable. In this article, the second of a 2-part series, we explore the consequences of and potential solutions to racism and inequality in cancer care. Cancer Cytopathol 128(2):83–84
Goel N, Westrick AC, Bailey ZD, Hernandez A, Balise RR, Goldfinger E, Antoni MH, Stoler J, Kesmodel SB, Kobetz EN (2022) Structural racism and breast cancer-specific survival: impact of economic and racial residential segregation. Ann Surg 275(4):776–783
Cheng E, Soulos PR, Irwin ML, Cespedes Feliciano EM, Presley CJ, Fuchs CS, Meyerhardt JA, Gross CP (2021) Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers. JAMA Netw Open 4(12):e2139593
Unger JM, Moseley AB, Cheung CK, Osarogiagbon RU, Symington B, Ramsey SD, Hershman DL (2021) Persistent disparity: socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. J Clin Oncol 39(12):1339–1348
Saini G, Ogden A, McCullough LE, Torres M, Rida P, Aneja R (2019) Disadvantaged neighborhoods and racial disparity in breast cancer outcomes: the biological link. Cancer Causes Control 30(7):677–686
Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J, Elo I, Burke JG, O’Campo P (2006) The development of a standardized neighborhood deprivation index. J Urban Health 83(6):1041–1062
Census Tracts and Block Numbering Areas. https://www2.census.gov/geo/pdfs/reference/GARM/Ch10GARM.pdf
Kind AJH, Buckingham WR (2018) Making neighborhood-disadvantage metrics accessible—the neighborhood atlas. N Engl J Med 378(26):2456–2458
Research CfHD (2022) About the neighborhood atlas. 2022 (August 30, 2022)
Glassman B (2022) Multidimensional deprivation in the United States: 2017. 2019, 2022 (August 30, 2022)
Andrews MR, Tamura K, Claudel SE, Xu S, Ceasar JN, Collins BS, Langerman S, Mitchell VM, Baumer Y, Powell-Wiley TM (2020) Geospatial analysis of Neighborhood Deprivation Index (NDI) for the United States by County. J Maps 16(1):101–112
Slotman BA, Stinchcomb DG, Powell-Wiley TM, Ostendorf DM, Saelens BE, Gorin AA, Zenk SN, Berrigan D (2022) Environmental data and methods from the Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures environmental working group. Data Brief 41:108002
National Cancer Institute Surveillance EaERP (2022) Census Tract-level SES and Rurality Database (2006–2018). 2022 (August 30, 2022)
Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711
Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482
Trinidad S, Brokamp C, Mor Huertas A, Beck AF, Riley CL, Rasnik E, Falcone R, Kotagal M (2022) Use of area-based socioeconomic deprivation indices: a scoping review and qualitative analysis. Health Aff 41(12):1804–1811
Krieger N, Williams DR, Moss NE (1997) Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 18:341–378
Hardeman RR, Homan PA, Chantarat T, Davis BA, Brown TH (2022) Improving the measurement of structural racism to achieve antiracist health policy. Health Aff 41(2):179–186
Williams DR, Yan Y, Jackson JS, Anderson NB (1997) Racial Differences in physical and mental health: socio-economic status stress and discrimination. J Health Psychol 2(3):335–351
Krieger N, Sidney S (1996) Racial discrimination and blood pressure: the CARDIA Study of young black and white adults. Am J Public Health 86(10):1370–1378
Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM (2005) Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med 61(7):1576–1596
Torres-Harding SR, Andrade AL, Romero Diaz CE (2012) The Racial Microaggressions Scale (RMAS): a new scale to measure experiences of racial microaggressions in people of color. Cult Divers Ethnic Minor Psychol 18(2):153–164
Waelde LC, Pennington D, Mahan C, Mahan R, Kabour M, Marquett R (2010) Psychometric properties of the Race-Related Events Scale. Psychol Trauma Theory Res Pract Policy 2(1):4–11
Bird ST, Bogart LM (2001) Perceived race-based and socioeconomic status(SES)-based discrimination in interactions with health care providers. Ethn Dis 11(3):554–563
Hausmann LR, Kressin NR, Hanusa BH, Ibrahim SA (2010) Perceived racial discrimination in health care and its association with patients’ healthcare experiences: does the measure matter? Ethn Dis 20(1):40–47
Peek ME, Nunez-Smith M, Drum M, Lewis TT (2011) Adapting the everyday discrimination scale to medical settings: reliability and validity testing in a sample of African American patients. Ethn Dis 21(4):502–509
Kershaw KN, Diez Roux AV, Burgard SA, Lisabeth LD, Mujahid MS, Schulz AJ (2011) Metropolitan-level racial residential segregation and black-white disparities in hypertension. Am J Epidemiol 174(5):537–545
Kershaw KN, Osypuk TL, Do DP, De Chavez PJ, Diez Roux AV (2015) Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Circulation 131(2):141–148
Alson JG, Robinson WR, Pittman L, Doll KM (2021) Incorporating measures of structural racism into population studies of reproductive health in the United States: a narrative review. Health Equity 5(1):49–58
Groos M, Wallace M, Hardeman R, Theall KP (2018) Measuring inequity: a systematic review of methods used to quantify structural racism. J Health Disparities Res Pract 11(2):13
Adkins-Jackson PB, Chantarat T, Bailey ZD, Ponce NA (2022) Measuring structural racism: a guide for epidemiologists and other health researchers. Am J Epidemiol 191(4):539–547
Jahn JL (2021) Invited commentary: comparing approaches to measuring structural racism. Am J Epidemiol 191(4):548–551
Dean LT, Thorpe RJ, Jr (2022) What structural racism is (or is not) and how to measure it: clarity for public health and medical researchers. Am J Epidemiol
Dougherty GB, Golden SH, Gross AL, Colantuoni E, Dean LT (2020) Measuring structural racism and its association with BMI. Am J Prev Med 59(4):530–537
James P, Hart JE, Hipp JA, Mitchell JA, Kerr J, Hurvitz PM, Glanz K, Laden F (2017) GPS-based exposure to greenness and walkability and accelerometry-based physical activity. Cancer Epidemiol Biomark Prev 26(4):525–532
Sweeney MR, Nichols HB, Jones RR, Olshan AF, Keil AP, Engel LS, James P, Jackson CL, Sandler DP, White AJ (2022) Light at night and the risk of breast cancer: findings from the Sister study. Environ Int 169:107495
Iyer HS, Valeri L, James P, Chen JT, Hart JE, Laden F, Holmes MD, Rebbeck TR (2020) The contribution of residential greenness to mortality among men with prostate cancer: a registry-based cohort study of Black and White men. Environ Epidemiol 4(2):e087
Health NCfE (2011) Impact of the built environment on health. In: Healthy community design. vol 2022. Centers for Disease Control
Berkovitz C (2020) Environmental racism has left black communities especially vulnerable to COVID-19. In: Rights & justice, vol 2022. The Century Foundation
Poisonous Homes: The Fight for Environmental Justice in Federally Assisted Housing. https://www.povertylaw.org/wp-content/uploads/2020/06/environmental_justice_report_final-rev2.pdf
Ashing KT, Jones V, Bedell F, Phillips T, Erhunmwunsee L (2022) Calling attention to the role of race-driven societal determinants of health on aggressive tumor biology: a focus on Black Americans. JCO Oncol Pract 18(1):15–22
Naess O, Piro FN, Nafstad P, Smith GD, Leyland AH (2007) Air pollution, social deprivation, and mortality: a multilevel cohort study. Epidemiology 18(6):686–694
Jbaily A, Zhou X, Liu J, Lee TH, Kamareddine L, Verguet S, Dominici F (2022) Air pollution exposure disparities across US population and income groups. Nature 601(7892):228–233
Jones MR, Diez-Roux AV, Hajat A, Kershaw KN, O’Neill MS, Guallar E, Post WS, Kaufman JD, Navas-Acien A (2014) Race/ethnicity, residential segregation, and exposure to ambient air pollution: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Public Health 104(11):2130–2137
Schulz AJ, Omari A, Ward M, Mentz GB, Demajo R, Sampson N, Israel BA, Reyes AG, Wilkins D (2020) Independent and joint contributions of economic, social and physical environmental characteristics to mortality in the Detroit Metropolitan Area: a study of cumulative effects and pathways. Health Place 65:102391
James W, Jia C, Kedia S (2012) Uneven magnitude of disparities in cancer risks from air toxics. Int J Environ Res Public Health 9(12):4365–4385
Turner MC, Andersen ZJ, Baccarelli A, Diver WR, Gapstur SM, Pope CA 3rd, Prada D, Samet J, Thurston G, Cohen A (2020) Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA Cancer J Clin 70(6):460–479
Huang CC, Ho CH, Chen YC, Hsu CC, Lin HJ, Tian YF, Wang JJ, Guo HR (2020) Impact of carbon monoxide poisoning on the risk of breast cancer. Sci Rep 10(1):20450
Kazemiparkouhi F, Eum KD, Wang B, Manjourides J, Suh HH (2020) Long-term ozone exposures and cause-specific mortality in a US Medicare cohort. J Expo Sci Environ Epidemiol 30(4):650–658
Eum KD, Kazemiparkouhi F, Wang B, Manjourides J, Pun V, Pavlu V, Suh H (2019) Long-term NO2 exposures and cause-specific mortality in American older adults. Environ Int 124:10–15
Santibanez-Andrade M, Quezada-Maldonado EM, Osornio-Vargas A, Sanchez-Perez Y, Garcia-Cuellar CM (2017) Air pollution and genomic instability: the role of particulate matter in lung carcinogenesis. Environ Pollut 229:412–422
Pritchett N, Spangler EC, Gray GM, Livinski AA, Sampson JN, Dawsey SM, Jones RR (2022) Exposure to outdoor particulate matter air pollution and risk of gastrointestinal cancers in adults: a systematic review and meta-analysis of epidemiologic evidence. Environ Health Perspect 130(3):36001
Youogo LMK, Parent ME, Hystad P, Villeneuve PJ (2022) Ambient air pollution and prostate cancer risk in a population-based Canadian case-control study. Environ Epidemiol 6(4):e219
Chen J, Rodopoulou S, Strak M, de Hoogh K, Taj T, Poulsen AH, Andersen ZJ, Bellander T, Brandt J, Zitt E et al (2022) Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project. Br J Cancer 126(10):1499–1507
Yeh HL, Hsu SW, Chang YC, Chan TC, Tsou HC, Chang YC, Chiang PH (2017) Spatial analysis of ambient PM2.5 exposure and bladder cancer mortality in Taiwan. Int J Environ Res Public Health 14(5):508
Zare Sakhvidi MJ, Lequy E, Goldberg M, Jacquemin B (2020) Air pollution exposure and bladder, kidney and urinary tract cancer risk: a systematic review. Environ Pollut 267:115328
Hwang J, Bae H, Choi S, Yi H, Ko B, Kim N (2020) Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea. Sci Rep 10(1):5392
Andersen ZJ, Stafoggia M, Weinmayr G, Pedersen M, Galassi C, Jorgensen JT, Oudin A, Forsberg B, Olsson D, Oftedal B et al (2017) Long-term exposure to ambient air pollution and incidence of postmenopausal breast cancer in 15 european cohorts within the ESCAPE project. Environ Health Perspect 125(10):107005
Andersen ZJ, Ravnskjaer L, Andersen KK, Loft S, Brandt J, Becker T, Ketzel M, Hertel O, Lynge E, Brauner EV (2017) Long-term exposure to fine particulate matter and breast cancer incidence in the Danish Nurse Cohort Study. Cancer Epidemiol Biomark Prev 26(3):428–430
Hart JE, Bertrand KA, DuPre N, James P, Vieira VM, Tamimi RM, Laden F (2016) Long-term particulate matter exposures during adulthood and risk of breast cancer incidence in the nurses’ health study ii prospective cohort. Cancer Epidemiol Biomark Prev 25(8):1274–1276
Prada D, Baccarelli AA, Terry MB, Valdez L, Cabrera P, Just A, Kloog I, Caro H, Garcia-Cuellar C, Sanchez-Perez Y et al (2021) Long-term PM2.5 exposure before diagnosis is associated with worse outcome in breast cancer. Breast Cancer Res Treat 188(2):525–533
Villanueva C, Chang J, Ziogas A, Bristow RE, Vieira VM (2021) Ambient air pollution and ovarian cancer survival in California. Gynecol Oncol 163(1):155–161
Arias-Perez RD, Taborda NA, Gomez DM, Narvaez JF, Porras J, Hernandez JC (2020) Inflammatory effects of particulate matter air pollution. Environ Sci Pollut Res Int 27(34):42390–42404
Li R, Zhou R, Zhang J (2018) Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases. Oncol Lett 15(5):7506–7514
Manisalidis I, Stavropoulou E, Stavropoulos A, Bezirtzoglou E (2020) Environmental and health impacts of air pollution: a review. Front Public Health 8:14
Peluso M, Ceppi M, Munnia A, Puntoni R, Parodi S (2001) Analysis of 13 (32)P-DNA postlabeling studies on occupational cohorts exposed to air pollution. Am J Epidemiol 153(6):546–558
Dunn BP (1991) Carcinogen adducts as an indicator for the public health risks of consuming carcinogen-exposed fish and shellfish. Environ Health Perspect 90:111–116
Peluso M, Airoldi L, Armelle M, Martone T, Coda R, Malaveille C, Giacomelli G, Terrone C, Casetta G, Vineis P (1998) White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol Biomark Prev 7(4):341–346
Deben C, Van den Bossche J, Van Der Steen N, Lardon F, Wouters A, de Beeck KO, Hermans C, Jacobs J, Peeters M, Van Camp G et al (2017) Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants. Tumour Biol 39(2):1010428317694327
Zhou W, Tian D, He J, Wang Y, Zhang L, Cui L, Jia L, Zhang L, Li L, Shu Y et al (2016) Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation. Oncotarget 7(15):20691–20703
Yu XJ, Yang MJ, Zhou B, Wang GZ, Huang YC, Wu LC, Cheng X, Wen ZS, Huang JY, Zhang YD et al (2015) Characterization of somatic mutations in air pollution-related lung cancer. EBioMedicine 2(6):583–590
Jiang CL, He SW, Zhang YD, Duan HX, Huang T, Huang YC, Li GF, Wang P, Ma LJ, Zhou GB et al (2017) Air pollution and DNA methylation alterations in lung cancer: a systematic and comparative study. Oncotarget 8(1):1369–1391
Letellier N, Wing SE, Yang JA, Gray SW, Benmarhnia T, Erhunmwunsee L, Jankowska MM (2022) The role of neighborhood air pollution exposure on somatic non-small cell lung cancer mutations in the Los Angeles Basin (2013–2018). Int J Environ Res Public Health 19(17):11027
Wang Z, Zhai Z, Chen C, Tian X, Xing Z, Xing P, Yang Y, Zhang J, Wang C, Dong L (2022) Air pollution particles hijack peroxidasin to disrupt immunosurveillance and promote lung cancer. Elife 11:e75345
Dobreva ZG, Kostadinova GS, Popov BN, Petkov GS, Stanilova SA (2015) Proinflammatory and anti-inflammatory cytokines in adolescents from Southeast Bulgarian cities with different levels of air pollution. Toxicol Ind Health 31(12):1210–1217
Niu BY, Li WK, Li JS, Hong QH, Khodahemmati S, Gao JF, Zhou ZX (2020) Effects of DNA damage and oxidative stress in human bronchial epithelial cells exposed to PM2.5 from Beijing, China, in Winter. Int J Environ Res Public Health 17(13):4874
Reyes-Caballero H, Rao X, Sun Q, Warmoes MO, Lin P, Sussan TE, Park B, Fan TW, Maiseyeu A, Rajagopalan S et al (2020) Author correction: air pollution-derived particulate matter dysregulates hepatic Krebs cycle, glucose and lipid metabolism in mice. Sci Rep 10(1):5082
Conroy SM, Shariff-Marco S, Koo J, Yang J, Keegan TH, Sangaramoorthy M, Hertz A, Nelson DO, Cockburn M, Satariano WA et al (2017) Racial/ethnic differences in the impact of neighborhood social and built environment on breast cancer risk: the neighborhoods and breast cancer study. Cancer Epidemiol Biomark Prev 26(4):541–552
Mayhand KN, Handorf EA, Ortiz AG, Gonzalez ET, Devlin A, Sorice KA, Esnaola N, Fisher S, Lynch SM (2021) Effect of neighborhood and individual-level socioeconomic factors on colorectal cancer screening adherence. Int J Environ Res Public Health 18(9):4398
Rosenzweig MQ, Althouse AD, Sabik L, Arnold R, Chu E, Smith TJ, Smith K, White D, Schenker Y (2021) The association between area deprivation index and patient-reported outcomes in patients with advanced cancer. Health Equity 5(1):8–16
DeRouen MC, Yang J, Jain J, Weden MM, Gomez SL, Shariff-Marco S (2022) Disparities in prostate cancer survival according to neighborhood archetypes, a population-based study. Urology 163:138–147
Shariff-Marco S, Yang J, John EM, Sangaramoorthy M, Hertz A, Koo J, Nelson DO, Schupp CW, Shema SJ, Cockburn M et al (2014) Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the Neighborhood and Breast Cancer Study. Cancer Epidemiol Biomark Prev 23(5):793–811
Gomez SL, Shariff-Marco S, DeRouen M, Keegan TH, Yen IH, Mujahid M, Satariano WA, Glaser SL (2015) The impact of neighborhood social and built environment factors across the cancer continuum: current research, methodological considerations, and future directions. Cancer 121(14):2314–2330
Aviv A, Anderson JJ, Shay JW (2017) Mutations, cancer and the telomere length paradox. Trends Cancer 3(4):253–258
Powell-Wiley TM, Gebreab SY, Claudel SE, Ayers C, Andrews MR, Adu-Brimpong J, Berrigan D, Davis SK (2020) The relationship between neighborhood socioeconomic deprivation and telomere length: the 1999–2002 National Health and Nutrition Examination Survey. SSM Popul Health 10:100517
Zhu X, Han W, Xue W, Zou Y, Xie C, Du J, Jin G (2016) The association between telomere length and cancer risk in population studies. Sci Rep 6:22243
Urquidi V, Tarin D, Goodison S (1998) Telomerase in cancer: clinical applications. Ann Med 30(5):419–430
Brown R, Hailu EM, Needham BL, Roux AD, Seeman TE, Lin J, Mujahid MS (2021) Neighborhood social environment and changes in leukocyte telomere length: the Multi-Ethnic Study of Atherosclerosis (MESA). Health Place 67:102488
Alexeeff SE, Schaefer CA, Kvale MN, Shan J, Blackburn EH, Risch N, Ranatunga DK, Jorgenson E, Hoffmann TJ, Sakoda LC et al (2019) Telomere length and socioeconomic status at neighborhood and individual levels among 80,000 adults in the Genetic Epidemiology Research on Adult Health and Aging cohort. Environ Epidemiol 3(3):e049
Coimbra BM, Carvalho CM, van Zuiden M, Williamson RE, Ota VK, Mello AF, Belangero SI, Olff M, Mello MF (2022) The impact of neighborhood context on telomere length: a systematic review. Health Place 74:102746
Barber LE, Zirpoli GR, Cozier YC, Rosenberg L, Petrick JL, Bertrand KA, Palmer JR (2021) Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women. Breast Cancer Res 23(1):108
Basudhar D, Glynn SA, Greer M, Somasundaram V, No JH, Scheiblin DA, Garrido P, Heinz WF, Ryan AE, Weiss JM et al (2017) Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer. Proc Natl Acad Sci USA 114(49):13030–13035
Guidi J, Lucente M, Sonino N, Fava GA (2021) Allostatic load and its impact on health: a systematic review. Psychother Psychosom 90(1):11–27
Zhao H, Song R, Ye Y, Chow WH, Shen J (2021) Allostatic score and its associations with demographics, healthy behaviors, tumor characteristics, and mitochondrial DNA among breast cancer patients. Breast Cancer Res Treat 187(2):587–596
Costanzo ES, Sood AK, Lutgendorf SK (2011) Biobehavioral influences on cancer progression. Immunol Allergy Clin N Am 31(1):109–132
Nazmi A, Diez Roux A, Ranjit N, Seeman TE, Jenny NS (2010) Cross-sectional and longitudinal associations of neighborhood characteristics with inflammatory markers: findings from the multi-ethnic study of atherosclerosis. Health Place 16(6):1104–1112
Iyer HS, Hart JE, James P, Elliott EG, DeVille NV, Holmes MD, De Vivo I, Mucci LA, Laden F, Rebbeck TR (2022) Impact of neighborhood socioeconomic status, income segregation, and greenness on blood biomarkers of inflammation. Environ Int 162:107164
Nagar SD, Conley AB, Sharma S, Rishishwar L, Jordan IK, Marino-Ramirez L (2021) Comparing genetic and socioenvironmental contributions to ethnic differences in C-reactive protein. Front Genet 12:738485
Muscatell KA, Brosso SN, Humphreys KL (2020) Socioeconomic status and inflammation: a meta-analysis. Mol Psychiatry 25(9):2189–2199
Liu RS, Aiello AE, Mensah FK, Gasser CE, Rueb K, Cordell B, Juonala M, Wake M, Burgner DP (2017) Socioeconomic status in childhood and C reactive protein in adulthood: a systematic review and meta-analysis. J Epidemiol Community Health 71(8):817–826
Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Zimmerman MB, Penedo FJ, Lucci JA 3rd, Ganjei-Azar P et al (2012) Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 30(23):2885–2890
Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I (2006) Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 24(7):1105–1111
Kroenke CH, Quesenberry C, Kwan ML, Sweeney C, Castillo A, Caan BJ (2013) Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study. Breast Cancer Res Treat 137(1):261–271
Umberson D (1987) Family status and health behaviors: social control as a dimension of social integration. J Health Soc Behav 28(3):306–319
Hinzey A, Gaudier-Diaz MM, Lustberg MB, DeVries AC (2016) Breast cancer and social environment: getting by with a little help from our friends. Breast Cancer Res 18(1):54
Brisson D (2014) Neighborhood social cohesion. Oxford-Bibliographics in Social Work
Rosenblatt AM, Crews DC, Powe NR, Zonderman AB, Evans MK, Tuot DS (2021) Association between neighborhood social cohesion, awareness of chronic diseases, and participation in healthy behaviors in a community cohort. BMC Public Health 21(1):1611
Dustin T, Duncan IK (2014) Neighborhoods and health, 2nd edn. Oxford University Press, Oxford
Martin AL, Brown RE (2010) The lonely mouse: verification of a separation-induced model of depression in female mice. Behav Brain Res 207(1):196–207
Grippo AJ, Gerena D, Huang J, Kumar N, Shah M, Ughreja R, Carter CS (2007) Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles. Psychoneuroendocrinology 32(8–10):966–980
Olsson IAS, Westlund K (2007) More than numbers matter: the effect of social factors on behaviour and welfare of laboratory rodents and non-human primates. Appl Anim Behav Sci 103(3):229–254
Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M, Li X, Li Y, Xiong W, Li G et al (2020) Chronic stress promotes cancer development. Front Oncol 10:1492
Antoni MH, Bouchard LC, Jacobs JM, Lechner SC, Jutagir DR, Gudenkauf LM, Carver CS, Lutgendorf S, Cole SW, Lippman M et al (2016) Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: an exploratory analysis. Psychoneuroendocrinology 74:269–277
Ross K (2008) Mapping pathways from stress to cancer progression. J Natl Cancer Inst 100(13):914–915
Kubzansky LD, Seeman TE, Glymour MM (2014) Biological pathways linking social conditions and health: plausible mechanisms and emerging puzzles. In: Berkman LF, Kawachi I, Glymour MM (eds) Social epidemiology. Oxford University Press, Oxford
Adam EK, Hawkley LC, Kudielka BM, Cacioppo JT (2006) Day-to-day dynamics of experience–cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci USA 103(45):17058–17063
Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW (2006) Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12(2):369–375
Xia N, Li H (2018) Loneliness, social isolation, and cardiovascular health. Antioxid Redox Signal 28(9):837–851
Carter SE, Ong ML, Simons RL, Gibbons FX, Lei MK, Beach SRH (2019) The effect of early discrimination on accelerated aging among African Americans. Health Psychol 38(11):1010–1013
Chae DH, Epel ES, Nuru-Jeter AM, Lincoln KD, Taylor RJ, Lin J, Blackburn EH, Thomas SB (2016) Discrimination, mental health, and leukocyte telomere length among African American men. Psychoneuroendocrinology 63:10–16
Brody GH, Miller GE, Yu T, Beach SR, Chen E (2016) Supportive family environments ameliorate the link between racial discrimination and epigenetic aging: a replication across two longitudinal cohorts. Psychol Sci 27(4):530–541
Hailu EM, Lewis TT, Needham BL, Lin J, Seeman TE, Mujahid MS (2021) Longitudinal associations between discrimination, neighborhood social cohesion, and telomere length: the multi-ethnic study of atherosclerosis (MESA). J Gerontol A Biol Sci Med Sci
Krieger N, Jahn JL, Waterman PD (2017) Jim Crow and estrogen-receptor-negative breast cancer: US-born black and white non-Hispanic women, 1992–2012. Cancer Causes Control 28(1):49–59
Perry LM, Walsh LE, Horswell R, Miele L, Chu S, Melancon B, Lefante J, Blais CM, Rogers JL, Hoerger M (2021) Racial disparities in end-of-life care between black and white adults with metastatic cancer. J Pain Symptom Manag 61(2):342–349
Penner LA, Harper FWK, Dovidio JF, Albrecht TL, Hamel LM, Senft N, Eggly S (2017) The impact of Black cancer patients’ race-related beliefs and attitudes on racially-discordant oncology interactions: a field study. Soc Sci Med 191:99–108
Penner LA, Dovidio JF, Hagiwara N, Foster T, Albrecht TL, Chapman RA, Eggly S (2016) An analysis of race-related attitudes and beliefs in Black cancer patients: implications for health care disparities. J Health Care Poor Underserved 27(3):1503–1520
Manning M, Lucas T, Purrington K, Thompson H, Albrecht TL, Penner L (2022) Moderators of the effects of perceived racism and discrimination on cancer-related health behaviors among two samples of African Americans. Soc Sci Med 114982
Adam EK, Heissel JA, Zeiders KH, Richeson JA, Ross EC, Ehrlich KB, Levy DJ, Kemeny M, Brodish AB, Malanchuk O et al (2015) Developmental histories of perceived racial discrimination and diurnal cortisol profiles in adulthood: a 20-year prospective study. Psychoneuroendocrinology 62:279–291
Cuevas AG, Reitzel LR, Adams CE, Cao Y, Nguyen N, Wetter DW, Watkins KL, Regan SD, McNeill LH (2014) Discrimination, affect, and cancer risk factors among African Americans. Am J Health Behav 38(1):31–41
Forde AT, Sims M, Wang X, Barber S, Diez Roux AV (2021) The role of perceived discrimination in predicting changes in health behaviours among African Americans in the Jackson Heart Study. J Epidemiol Community Health 75(12):1222–1231
Pantesco EJ, Leibel DK, Ashe JJ, Waldstein SR, Katzel LI, Liu HB, Weng NP, Evans MK, Zonderman AB, Beatty Moody DL (2018) Multiple forms of discrimination, social status, and telomere length: interactions within race. Psychoneuroendocrinology 98:119–126
Liu SY, Kawachi I (2017) Discrimination and telomere length among older adults in the United States. Public Health Rep 132(2):220–230
Kershaw KN, Lewis TT, Diez Roux AV, Jenny NS, Liu K, Penedo FJ, Carnethon MR (2016) Self-reported experiences of discrimination and inflammation among men and women: the multi-ethnic study of atherosclerosis. Health Psychol 35(4):343–350
Cunningham TJ, Seeman TE, Kawachi I, Gortmaker SL, Jacobs DR, Kiefe CI, Berkman LF (2012) Racial/ethnic and gender differences in the association between self-reported experiences of racial/ethnic discrimination and inflammation in the CARDIA cohort of 4 US communities. Soc Sci Med 75(5):922–931
Cobb RJ, Parker LJ, Thorpe RJ (2020) Self-reported instances of major discrimination, race/ethnicity, and inflammation among older adults: evidence from the health and retirement study. J Gerontol A Biol Sci Med Sci 75(2):291–296
Forde AT, Sims M, Muntner P, Lewis T, Onwuka A, Moore K, Diez Roux AV (2020) Discrimination and hypertension risk among African Americans in the Jackson Heart Study. Hypertension 76(3):715–723
Forde AT, Lewis TT, Kershaw KN, Bellamy SL, Diez Roux AV (2021) Perceived discrimination and hypertension risk among participants in the multi-ethnic study of atherosclerosis. J Am Heart Assoc 10(5):e019541
Geronimus AT (1992) The weathering hypothesis and the health of African-American women and infants: evidence and speculations. Ethn Dis 2(3):207–221
Forde AT, Crookes DM, Suglia SF, Demmer RT (2019) The weathering hypothesis as an explanation for racial disparities in health: a systematic review. Ann Epidemiol 33(1–18):e13
Geronimus AT, Hicken M, Keene D, Bound J (2006) “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health 96(5):826–833
Bird CE, Seeman T, Escarce JJ, Basurto-Davila R, Finch BK, Dubowitz T, Heron M, Hale L, Merkin SS, Weden M et al (2010) Neighbourhood socioeconomic status and biological “wear and tear” in a nationally representative sample of US adults. J Epidemiol Community Health 64(10):860–865
Figueroa JF, Frakt AB, Jha AK (2020) Addressing social determinants of health: time for a polysocial risk score. JAMA 323(16):1553–1554
Kinner SA, Borschmann R (2020) Polysocial risk scores for assessing social determinants of health. JAMA 324(16):1680–1681
Javed Z, Valero-Elizondo J, Dudum R, Khan SU, Dubey P, Hyder AA, Xu J, Bilal U, Kash BA, Cainzos-Achirica M et al (2021) Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease. Am J Prev Cardiol 8:100251
Figueroa JF, Jha AK (2020) Polysocial risk scores for assessing social determinants of health-reply. JAMA 324(16):1681–1682
Zhang H, Hu H, Diller M, Hogan WR, Prosperi M, Guo Y, Bian J (2021) Semantic standards of external exposome data. Environ Res 197:111185
Vineis P, Robinson O, Chadeau-Hyam M, Dehghan A, Mudway I, Dagnino S (2020) What is new in the exposome? Environ Int 143:105887
Hu H, Zhao J, Savitz DA, Prosperi M, Zheng Y, Pearson TA (2020) An external exposome-wide association study of hypertensive disorders of pregnancy. Environ Int 141:105797
Acknowledgments
We thank our funders, National Cancer Institute Intramural Research Program, Center for Cancer Research, and the Cancer Prevention Fellowship Program for their support in completing this work.
Funding
This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI), Center for Cancer Research; Brittany Lord and Alexandra Harris are supported by the Cancer Prevention Fellowship Program.
Author information
Authors and Affiliations
Contributions
All authors contributed to the conception and design of the manuscript. The first draft of the manuscript was written by BL and A. H. B.L. prepared Fig. 1. Manuscript revisions and figure edits were completed by all authors. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lord, B.D., Harris, A.R. & Ambs, S. The impact of social and environmental factors on cancer biology in Black Americans. Cancer Causes Control 34, 191–203 (2023). https://doi.org/10.1007/s10552-022-01664-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-022-01664-w